Sodium Chloride Tablet
FDA Label NDC 57237-361

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rising Pharma Holdings, Inc. for the product Sodium Chloride (NDC 57237-361). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding tamper evident: do not use if imrinted safety seal under cap is broken or missingdrug facts, purpose, other ingredients, other, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other Ingredients

None

* Please review the disclaimer below.